Feasibility of placebo-controlled clinical trials of antipsychotic compounds in Europe.
RATIONALE: Placebo-controlled trials (PCTs) are still regulatory requirements for the licensing of new drugs. Most recent phase II and phase III PCTs of antipsychotics in schizophrenia have been conducted outside Europe. This development needs to be better understood. OBJECTIVES: To ascertain the a...
| Main Authors: | , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2002
|